Glutamate and glutamine are key amino acids in mammalian intermediary metabolism, intimately associated with aerobic metabolism via the tricarboxylic acid cycle, with ammonia metabolism and also involved in the synthetic pathways of numerous biologically important compounds (Meister, 1979) . Research in various aspects of the metabolism and function of these amino acids has been continuous since the earliest days of modern biochemical studies.
Glutamate and glutamine are key amino acids in mammalian intermediary metabolism, intimately associated with aerobic metabolism via the tricarboxylic acid cycle, with ammonia metabolism and also involved in the synthetic pathways of numerous biologically important compounds (Meister, 1979) . Research in various aspects of the metabolism and function of these amino acids has been continuous since the earliest days of modern biochemical studies.
The direction of these studies has traced a path through the traditional biochemical methodologies and now encompasses other powerful techniques such as immunohistochemistry and molecular biology.
What has become apparent from these multidisciplinary studies on different organ systems is a pattern of greater complexity and heterogeneity than previous work might have suggested. There is not only the expected intracellular and interorgan diversity, but intercellular heterogeneity is becoming a more commonly accepted phenomenon, even in organs Abbreviations used: GABA, DON, such as the liver (Gebhardt & Mecke, 1983; Haussinger, 1983; Sies & Haussinger, 1984) . Nowhere is this complexity and heterogeneity more apparent, nor more intensely studied, than in the nervous system (for reviews, Balazs & Cremer, 1973; Bradford, 1982; Hertz er al., 1983) . In the central nervous system, glutamate and its decarboxylation product, 4-aminobutyrate (GABA), may well function as important neurotransmitter substances. Thus superimposed on the 'normal' role of glutamate and glutamine in cellular metabolism with its accompanying transport systems and enzymes is the further complication of specific membrane-associated receptor proteins and the associated ion-channel systems. In addition, glutamate and related neuroexcitatory substances are also potentially neurotoxic. The pharmacological and toxicological consequences of multiple receptor types for excitatory dicarboxylic amino acids are only now being understood and exploited (Olney, 1983; Meldrum, 1985) . It is clear from this that exquisite regulatory mechanisms must be present to separate these various functions of ubiquitously distributed amino acids such as glutamate and glutamine. The homoeostatic regulation of the neuroactive amino acids is associated with a heterogeneity of enzyme distribution amongst the neurons and glial cells that make up the nervous system (Nicklas, 1983~) . Most current evidence would suggest that transmitter pools of glutamate are formed in glutamergic synaptic endings from glutamine via the activity of phosphateactivated glutaminase (EC 3.5.1.2), which catalyses the hydrolytic cleavage of glutamine to glutamate and ammonia. (Benjamin, 1981; Kvamme, 1984) . Glutamine synthesis in the brain appears to be principally associated with the activity of glutamine synthetase (EC 3.2.1.2) which catalyses the ATP-dependent amidation of glutamate (Meister, 1974) . This also serves to remove ammonia from the circulation since the urea cycle is inoperative in brain.
Early experiments in which animals were injected with radioactive precursors suggested that glutamine synthesis in the brain was compartmented. For example, when rats were injected intracisternally (thus avoiding problems with the blood-brain barrier) with ['4C]glutamate and the total pools of brain glutamate and glutamine acid-extracted, within minutes the radiospecific activity of the total glutamine was found to be several-fold higher than that of the total brain glutamate (Berl et al., 1962) . This indicated that the radioactive extracellular glutamate was metabolized in a biochemical compartment in which glutamine was synthesized before the radioactive glutamate could mix with the bulk of tissue glutamate. Based on a great deal of similar data in vivo and in vitro, Balazs et al. (1973) suggested the 'compartment' in which glutamine was actively synthesized was the astroglial cells of the brain. Subsequent immunohistochemical localization of glutamine synthetase in astrocytes in brain (Norenberg & Martinez-Hernandez, 1979 ) has definitively shown this interpretation based on biochemical studies to be correct. These findings immediately suggest problems of regulation of transport and metabolism which would not be so obvious in a less complex model. However, this complexity also allows for the separate regulation of the role of these amino acids in 'normal' metabolism and their possible role in neurotransmission.
From these studies the concept emerged of a 'glutamine cycle' between glia and nerve endings (Van den Berg & Garfinkel, 1971) . In this hypothesis, glutamate and GABA levels within their respective nerve terminals are maintained by glutamine derived from the extracellular space, which in turn can be replenished by synthesis in the glia via glutamine synthetase. In a series of studies we attempted to answer the question as to whether this really occurred (Nicklas, 1983~) . One consistent finding that emerged from the many earlier studies done with radioactive precursors of glutamate/glutamine was that radioactive acetate (either 4C-or H-labelled) is preferentially metabolized in the glutamine-synthesizing compartment of brain, i.e. the astrocyte, whereas radioactively labelled glucose is metabolized in all compartments (Van den Berg & Garfinkel, 197 1). Numerous studies have shown that when various central nervous system preparations are allowed to metabolize labelled glucose and/or acetate and then efflux of synaptic contents initiated by depolarization stimuli, there is a preferential efflux of glucose-labelled glutamate (Minchin, 1977 , Krespan et al., 1982 Nicklas, 1983~) . In our experiments (Nicklas, 1983a) , tissue slice pre arations from rat brain were incubated with a mixture of [ Clacetate to label endogenous pools of amino acids. The alkaloid veratridine was used to cause the efflux of synaptic glutamate and GABA. The proposed flow pathway from glutamine synthesis in glia to glutamine utilization in the nerve endings was blocked by using 6-diazo-5-oxo-~-norleucine (DON), an inhibitor of glutaminase, or L-methionine sulphoximine, an inhibitor of glutamine synthetase. It was possible to demonstrate that glutamate and GABA labelled from radioactive acetate metabolism (i.e. from glial metabolism) did indeed enter transmitter pools of these amino acids via glutamine. Moreover, the contribution of glutamine metabolism to the maintenance of transmitter amino acid levels seemed to be ?4 quantitatively important. The above studies were performed with preparations in vitro. Rothstein & Tabakoff (1984) reached a similar conclusion after inhibition of glutamine synthetase in vivo with methionine sulphoximine administered to rats intraventricularly. Striatal glutamine synthetase activity and glutamine levels were decreased substantially for days with no change in total glutamate levels.
However, the Ca2+ -dependent, K f -stimulated release of glutamate from striatal slices of treated animals was diminished by 50%. When glutamine was present in the perfusion medium in which release was measured, there was no difference in glutamate efflux between slices from control or treated animals. The same authors had previously reported that treatment of rats with intraventricular methionine sulphoximine decreased the activity of dopaminergic terminals in the striatum (Rothstein & Tabakoff, 1982) . The latter may be of physiological interest because it has been suggested that corticostriatal glutamergic inputs presynaptically facilitate the release of dopamine from nigrostriatal nerve endings. At the present time, there is every reason to conclude that the 'glutamine cycle' is operative in the central nervous system and is of quantitative and qualitative importance in the regulation of glutamate homoeostasis.
For some time we have attempted to apply these concepts to the study of the biochemical sequelae of excitotoxic amino acid analogues (Nicklas, 19833 ). The precise mechanism(s) by which these substances cause neuronal death has not been completely elucidated, and remains in some ways controversial. The question is not trivial since excitotoxic interactions have been suggested to underlie a number of pathological conditions (see Meldrum, 1985) . If these suggestions prove true, then an approach to rational therapy for these disorders must include an awareness of basic neurotoxic mechanisms. It has been shown that kainate incubated with responsive tissue slices (e.g. cerebellar or hippocampal slices) causes decreased adenylate charge and accompanying amino acid release into the incubation or perfusate medium (Nicklas et al., 1980; Krespan et al., 1982; Ferkany & Coyle, 1983) . Glial metabolism appears to be profoundly affected by such treatment. Glutamine synthesis is greatly inhibited (but not by direct inhibition of glutamine synthetase) and metabolism in the form of radioactive acetate metabolism severely compromised (Krespan et al., 1982) . Moreover, the glutamate which appears in the medium apparently arises in large part from the glial compartment. Acetate-labelled glutamate is released by the excitotoxins, whereas veratridine-stimulation releases primarily glucose-labelled amino acids. In addition, kainate preferentially releases the glutamate which accumulates in methionine sulphoximine-inhibited preparations; veratridine does not. In both cases, the results are consistent with glia being the prime source of glutamate released by kainate (Nicklas & Richie, 1987) . It is certainly not clear that these glial-related events play any role in the mechanism of neuronal death itself (e.g. see Hajos et al., 1986) . However, morphological studies with rat neostriatum in vivo and in vitro do show that kainate causes rapid ultrastructural alterations in glial cells which parallel neuronal changes (Matyja, 1986) . Although our working hypothesis is that all effects of these agents result from initial massive neuronal depolarization, direct effects of excitotoxins on glia also cannot be ruled out (Bowman & Kimelberg, 1984) . We have hypothesized that the gross effects on amino acid efflux and glutamine synthesis are consistent with a compromise of the glial cell structure such as swelling (Nicklas & Richie, 1987) . Glial swelling has been suggested to be associated with neuronal activity caused by excitatory stimuli; this osmotic swelling is associated with influx of chloride ion, perhaps via an CI ~ /HCO; antiport (see Van Gelder, 1983) . Chloride uptake is indeed increased by kainate (Nicklas et al., 1987) .
BIOCHEMICAL SOCl ETY TRANSACTIONS
This uptake is inhibited by stilbene analogues which inhibit the chloride/bicarbonate antiport; these compounds also greatly inhibit the efflux of amino acids and the decreased glutamine synthesis seen with kainate administration. These compounds have no effect on veratridine-stimulated efflux of transmitter amino acids.
The question always arises in experiments in vitro as to the relevance to the situation in vivo. Rothman (1985) has shown that the neurotoxicity of glutamate, N-methylaspartate and kainate in hippocampal tissue cultures is associated with chloride influx; toxicity could be prevented by incubation in low chloride-containing medium. Olney et al. (1984) have made similar observations with chick retinal preparations. We have confirmed the latter study with chick retina and also found that inhibitors of chloride/ bicarbonate exchange added to normal chloride medium prevent the acute toxic changes (which includes glial as well as neuronal swelling) caused by kainate or glutamate (Nicklas et al., 1986) . These findings obviously allow of interpretations other than our hypothesis which remain to be studied. However, the data do have intriguing implications for probing the various interactions between neurons and glia (e.g. the genesis of reactive astrocytes after neuronal damage) now under active investigation in many laboratories.
